Axion BioSystems, a leader in live-cell analysis tools, has announced the full integration of imaging innovator CytoSMART Technologies into the Axion BioSystems brand. The news, which follows the company’s 2022 acquisition of CytoSMART Technologies, reflects Axion’s expanding portfolio of live-cell analysis tools for researchers in stem cell biology, immuno-oncology, neurology, virology, toxicology, and other fields.